Gastroprotection by an Aluminium- and Magnesium Hydroxide-Containing Antacid in Rats

References

• Crohn B B, Rosenak B D. An exhibition of books shown at the Graduate Fortnight illustrating the progress of gastroenterology. Bull NY Acad Med 1935; 11: 74–80
   Google Scholar
• Sippy B W. Gastric and duodenal ulcers, medical cure by efficient removal of gastric juice corrosion. JAMA 1910; 64: 1625–1650
   Google Scholar
• Peterson W L, Sturdevant A L, Frankl H D, et al. Healing of duodenal ulcer with an antacid regimen. N Engl J Med 1977; 297: 341–345
   PubMed Web of Science ®Google Scholar
• Ippoliti A F, Sturdevant R AL, Isenberg J I. Cime-tidine versus intensive antacid therapy for duodenal ulcer. A multicenter trial. Gastroenterology 1978; 74: 393–395
   PubMed Web of Science ®Google Scholar
• Fedeli G, Anti M, Rapaccini G L, De Vitis I, Butti A, Civelo I M. A controlled study comparing cimetidine treatment to an intensive antacid regimen in the therapy of uncomplicated duodenal ulcer. Dig Dis Sci 1979; 24: 758–762
   PubMed Web of Science ®Google Scholar
• Berstad A, Rydning A, Aaland E, Kolstad B, Frislid K, Asseth J. Controlled clinical trial of duodenal ulcer healing with antacid tablets. Scand J Gastroenterol 1982; 17: 953–959
   PubMed Web of Science ®Google Scholar
• Laurisen K, Bytzer P, Hansen J, Bekker C, Rask-Madsen J. Comparison of ranitidine and high-dose antacid in the treatment of prepyloric or duodenal ulcer. A double-blind controlled trial. Scand J Gastroenterol 1985; 20: 123–138
   PubMed Web of Science ®Google Scholar
• Weberg R, Berstad A, Lange O, Schultz T, Aubert E. Duodenal ulcer healing with four antacid tablets daily. Scand J Gastroenterol 1985; 20: 1041–1045
   PubMed Web of Science ®Google Scholar
• Lux G, Henschel H, Rohner H G, et al. Treatment of duodenal ulcer with low dose antacids. Scand J Gastroenterol 1986; 21: 1063–1068
   PubMed Web of Science ®Google Scholar
• Bianchi-Porro G, Parente F, Lazzaroni M, Baroni S, Panza E. Medium-dose antacids versus cimetidine in the short-term treatment of duodenal ulcer. J Clin Gastroenterol 1986; 8: 141–154
   PubMed Web of Science ®Google Scholar
• Szelenyi I, Postius S, Engler H. Evidence for a functional cytoprotective effect produced by antacids in the rat stomach. Eur J Pharmacol 1983; 88: 403–406
   PubMed Web of Science ®Google Scholar
• Szelenyi J, Postius S. Functional cytoprotection by certain antacids and sucralfate in the rat stomach. Gastroneterology 1985; 88: 1604
   Web of Science ®Google Scholar
• Tarnawski A, Hollander D, Gergely H, Stachura J. Comparison of antacid, sucralfate, cimetidine and ranitidine in protection by the gastric mucosa against ethanol injury. Am J Med 1985; 79(suppl 2C)19–23
   PubMed Web of Science ®Google Scholar
• Hollander D, Tarnawski A, Gergely H. Protection against alcohol-induced gastric mucosal injury by aluminium-containing-compounds–sucralfate, antacids and aluminium sulphate. Scand J Gastroenterol 1986; 21(suppl 125)151–153
   PubMedGoogle Scholar
• Domschke W, Hagel J, Rupin H, Kaduk B. Antacids and gastric mucosal protection. Scand J Gastroenterol 1986; 21(suppl 125)144–149
   Google Scholar
• Tarnawski A, Hollander D, Cummings D, Krause W J, Gergely H, Zipser R D. Are antacids acid neutralizes only? Histologic, ultrastructural and functional changes in normal gastric mucosa induced by antacids. Gastroenterology 1984; 86: 1276
   Web of Science ®Google Scholar
• Massarrat S, Muller H G, Schmitz-Moormann. Risk factors for healing of duodenal ulcers under antacid treatment; do ulcer patients need individual treatment?. Gut 1988; 29: 291–297
   PubMed Web of Science ®Google Scholar
• Robert A, Nezamis J E, Lancaster C, Hanchar A J. Cytoprotection by prostaglandins in rats. Prevention of gastric necrosis produced by alcohol, HCI, NaOH, hypertonic NaCl, and thermal injury. Gastroenterology 1979; 77: 433–443
   PubMed Web of Science ®Google Scholar
• Konturek S J. Gastric cytoprotection. Scand J Gastroenterol 1985; 20: 543–553
   PubMed Web of Science ®Google Scholar
• Konturek S J. Physiological role of prostanoids in cytoprotection. Gastric protection, Cheli. Raven Press, New York 1988; 13–33
   Google Scholar
• Konturek S J, Brzozowski T, Piastucki I, Radecki T. Prevention of ethanol and aspirin-induced gastric mucosal lesions by paracetamol and salicylate in rats: role of endogenous prostaglandins. Gut 1982; 23: 536–540
   PubMed Web of Science ®Google Scholar
• Konturek S J, Piastucki I, Brzozowski T, et al. Gastric cytoprotection by epidermal growth factor. Gastroenterology 1981; 80: 4–9
   PubMed Web of Science ®Google Scholar
• Takagi K, Okabe S. The effect of drugs on the production and recovery process of the stress ulcer. Jpn J Pharmacol 1968; 18: 9–18
   PubMedGoogle Scholar
• Ahrens K H. Gastroprotektion durch Antazida. Verlag Ludwig Brunner GmbH, Nurnberg 1986
   Google Scholar
• Konturek S J, Radecki T, Piastucki I, Brzozowski T, Drozdowicz D. Gastroprotection by colloidal bismuth subcitrate (De-Nol) and sucralfate. Role of endogenous prostaglandins. Gut 1987; 28: 201–205
   PubMed Web of Science ®Google Scholar
• Konturek S J, Radecki T, Brzozowski T, Piastucki I, Zmuda A, Dembinska-Kiec A. Gastric cytoprotection by prostaglandins, ranitidine, and pro-banthine in rats. Scand J Gastroenterol 1981; 16: 7–12
   PubMed Web of Science ®Google Scholar
• Peskar B M, Lange K, Hoppe Y, Peskar B A. Etha-nol stimulates formation of leukotriene C4 in rat gastric mucosa. Prostglandins 1986; 31: 283–289
   PubMed Web of Science ®Google Scholar
• Wallace J L, Beck P L, Morris G P. Is there a role of leukotrienes as mediators of ethanol-induced gastric mucosal damage?. Am J Physiol 1988; 254: G1117–121
   Google Scholar
• Blum A. Stellung der Antazida in der moderner Ulcus-therapie. Dtsch Med Wochenshr 1985; 110: 3–7
   PubMed Web of Science ®Google Scholar